Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/93987
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hodge, G. | - |
dc.contributor.author | Holmes, M. | - |
dc.contributor.author | Jersmann, H. | - |
dc.contributor.author | Reynolds, P. | - |
dc.contributor.author | Hodge, S. | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | BMC Pulmonary Medicine, 2014; 14(1):85-1-85-11 | - |
dc.identifier.issn | 1471-2466 | - |
dc.identifier.issn | 1471-2466 | - |
dc.identifier.uri | http://hdl.handle.net/2440/93987 | - |
dc.description.abstract | Background: We have shown that chronic obstructive pulmonary disease (COPD) is associated with increased production of pro-inflammatory cytokines and the cytotoxic mediator, granzyme B by peripheral blood steroid resistant CD28nullCD137 + CD8+ T cells and granzyme B by NKT-like and NK cells. We hypothesized that we could target these pro-inflammatory/cytotoxic lymphocytes by inhibiting co-stimulation through CD137. Methods: Isolated PBMC from patients with COPD and healthy controls were stimulated with phytohaemagglutinin (PHA) ± blocking anti-CD137 ± 10-6 M methylprednislone (MP) (±stimulatory anti-CD137 ± control antibodies). Pro-inflammatory cytokine profiles and expression of granzyme B, by T, NKT-like CD28 ± subsets and NK cells were determined using flow cytometry. Results: There was a significant decrease in the percentage of T, NKT-like subsets and NK cells producing IFNγ, TNFα and granzyme B in all subjects in the presence of anti-CD137 blocking antibody compared with PHA alone (eg, 60% decrease in CD8 + granzyme B + cells) or MP. Stimulatory anti-CD137 was associated with an increase in the percentage of pro-inflammatory/cytotoxic cells. The inhibitory effect of anti-CD137 on IFNγ, TNFα and granzyme B production by CD28null cells was greater than by CD28+ cells. Conclusions: Blocking CD137 expression is associated with downregulation of IFNγ, TNFα and granzyme B by CD8+ T and NKT-like and NK cells. Targeting CD137 may have novel therapeutic implications for patients with COPD. | - |
dc.description.statementofresponsibility | Greg Hodge, Mark Holmes, Hubertus Jersmann, Paul N Reynolds and Sandra Hodge | - |
dc.language.iso | en | - |
dc.publisher | BioMed Central | - |
dc.rights | © 2014 Hodge et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. | - |
dc.source.uri | http://dx.doi.org/10.1186/1471-2466-14-85 | - |
dc.subject | COPD; Blocking CD137; CD28null T and NKT-like cells; NK cells; IFNγ and TNFα | - |
dc.title | Targeting peripheral blood pro-inflammatory cytotoxic lymphocytes by inhibiting CD137 expression: novel potential treatment for COPD | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1186/1471-2466-14-85 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Jersmann, H. [0000-0003-1763-2736] | - |
dc.identifier.orcid | Reynolds, P. [0000-0002-2273-1774] | - |
dc.identifier.orcid | Hodge, S. [0000-0002-3602-9927] [0000-0002-9401-298X] | - |
Appears in Collections: | Aurora harvest 2 Medicine publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
hdl_ 93987.pdf | Published version | 990.39 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.